The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
HLA class II alleles and haplotypes in Lithuanian children with type 1 diabetes and healthy children (HLA and type 1 diabetes)
Open accessAbstract
Objective. Type 1 diabetes mellitus is a slowly progressive autoimmune disease. The genetic background of type 1 diabetes mellitus is polygenic with the major disease locus located in the human leukocytes antigen (HLA) region. High risk and protective alleles, haplotypes, and genotypes have been determined in Lithuanian children with type 1 diabetes mellitus and healthy children. Material and methods. In this case-control study, 124 children with diabetes (55 males and 69 females; mean age, 9.2±3.9 years) were tested for HLA class II and compared with 78 healthy controls (43 males and 35 females; mean age, 10.8±3.4 years; range, 0–15 years). HLA DRB1, DQA1, and DQB1 alleles were genotyped using a polymerase chain reaction. Results. T1D risk-associated haplotypes (DR4)-DQA1*0301-DQB1*0302, (DR3)- DQA1*0501-DQB1*0201, and (DR1)-DQA1*0101-04-DQB1*0501 were more prevalent among children with diabetes than controls (50.0%, 41.1%, and 37.9% vs. 10.3%, 5.1%, and 24.4%, P<0.001). The haplotypes (DR4)-DQA1*0301-DQB1*0302 and (DR3)-DQA1*0501-DQB1*0201 increased T1D risk by 8.75 and 12.93 times, respectively (P<0.001). Protective haplotypes (DR2)- DQA1*0102-B1*0602, (DR11/12/13)-DQA1*05-DQB1*0301, and (DR13)-DQA1*0103- DQB1*0603 were significantly more prevalent among controls than children with diabetes (25.6%, 33.3%, 19.2% vs. 0%, 3.2%, 0%; P<0.001). These frequencies are quite similar to those from neighbor countries with varying incidence of type 1 diabetes mellitus. Conclusions. HLA class II haplotypes associated with type 1 diabetes mellitus positively or negatively were the same in Lithuanian children as in other European Caucasian populations. Differences in incidence and clinical manifestations of type 1 diabetes might be due to different environmental factors and/or lifestyle.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetics is also unlikely to explain the decreased prevalence of autoantibodies related to IA‐2A, as human leucocyte antigen (HLA) class II haplotypes associated with type 1 diabetes were similar in Lithuanian schoolchildren compared with other European Caucasian populations [ 10 ].”
From Islet autoantibody profiles associated with higher diabetes risk in Lithuanian compared with English schoolchildren (2020) · cites this paper as [10]
Citations
Cites
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
Epstein, F. H., Atkinson, M. A., & Maclaren, N. K. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312107 · Cited by 1,078
Genetics of type 1 diabetes mellitus
Pociot, F., & McDermott, M. F. (2002) · Genes & Immunity · doi:10.1038/sj.gene.6363875 · Cited by 359
Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.
Caillat-Zucman, S., Garchon, H. J., Timsit, J., Assan, R., Boitard, C., Djilali-Saiah, I., Bougnères, P., & Bach, J. F. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116110 · Cited by 289
Lambert, A. P., Gillespie, K. M., Thomson, G., Cordell, H. J., Todd, J. A., Gale, E. A. M., & Bingley, P. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032084 · Cited by 241
Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes.
Sabbah, E., Savola, K., Ebeling, T., Kulmala, P., Vähäsalo, P., Ilonen, J., Salmela, P. I., & Knip, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1326 · Cited by 219
Kawabata, Y., Ikegami, H., Kawaguchi, Y., Fujisawa, T., Shintani, M., Ono, M., Nishino, M., Uchigata, Y., Lee, I., & Ogihara, T. (2002) · Diabetes · doi:10.2337/diabetes.51.2.545 · Cited by 201
Genetic control of autoimmunity in Type I diabetes and associated disorders
Redondo, M. J., & Eisenbarth, G. S. (2002) · Diabetologia · doi:10.1007/s00125-002-0781-1 · Cited by 178
Nejentsev, S., Sjöroos, M., Soukka, T., Knip, M., Simell, O., Lövgren, T., & Ilonen, J. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00186.x · Cited by 164
Hermann, R., Turpeinen, H., Laine, A.-P., Veijola, R., Knip, M., Simell, O., Sipilä, I., Åkerblom, H. K., & Ilonen, J. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00071.x · Cited by 146
Kulmala, P., Savola, K., Reijonen, H., Veijola, R., Vähäsalo, P., Karjalainen, J., Tuomilehto‐Wolf, E., Ilonen, J., Tuomilehto, J., Åkerblom, H. K., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.1.48 · Cited by 96
Cited by
El-Ziny, M., Salem, N. A., El-Hawary, A. K., Chalaby, N. M., & Elsharkawy, A. A. (2014) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.1171 · Cited by 87
Prevention or acceleration of type 1 diabetes by viruses
Ghazarian, L., Diana, J., Simoni, Y., Beaudoin, L., & Lehuen, A. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1042-1 · Cited by 50
Association of HLA-DR-DQ polymorphisms with diabetes in Tunisian patients
Fekih‐Mrissa, N., Mrad, M., Ouertani, H., Baatour, M., Sayeh, A., Nsiri, B., Lamine, K., Zidi, B., & Gritli, N. (2013) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2013.01.012 · Cited by 24
Saad, F. M., Mahmoud, L. A., Ali, A. M., Omer, I., & Abdullah, M. A. (2020) · Sudanese Journal of Paediatrics · doi:10.24911/sjp.106-1587542600 · Cited by 20
Ostrauskas, R., Žalinkevičius, R., Jurgevičienė, N., Radzevičienė, L., & Lašaitė, L. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-813 · Cited by 26
Metadata
- Authors
- Skrodenienė, E., Marčiulionytė, D., Padaiga, Ž., Jašinskienė, E., Sadauskaitė-Kuehne, V., Sanjeevi, C., & Ludvigsson, J.
- Affiliations
- Lithuanian University of Health Sciences (LT)
- Institute of Endocrinology, Kaunas University of Medicine
- Karolinska Institutet (SE)
- Linköping University (SE)
- Corresponding author
- Skrodenienė, Erika
- Venue
- Medicina
- Publisher
- MDPI AG
- Published
- 2010-08-11
- Volume
- 46
- Issue
- 8
- Pages
- 505
- ISSN
- 1010-660X (ISSN-L)
- 1648-9144
- OpenAlex
- W1491767003
- Cited by
- 14
- References
- 26
- Citations by year
- 2024: 1 · 2020: 3 · 2017: 1 · 2014: 3 · 2013: 1 · 2012: 1
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Medicina (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lithuanian University of Health Sciences (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 1 diabetes, HLA class II alleles, HLA haplotypes, HLA-DRB1, HLA-DQA1, HLA-DQB1, genetic risk factors, protective haplotypes, Lithuanian children, autoimmune disease genetics, HLA-DR4, HLA-DR3, HLA-DR13, HLA-DR2
- MeSH terms
- Adolescent, Alleles, Child, Child, Preschool, Data Interpretation, Statistical, Diabetes Mellitus, Type 1, Female, Haplotypes, HLA Antigens, Humans, Infant, Infant, Newborn, Life Style, Lithuania, Male, Risk Factors, Incidence, Case-Control Studies, Polymerase Chain Reaction, Statistics, Nonparametric, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HLA class II alleles and haplotypes in Lithuanian children with type 1 diabetes and healthy children (HLA and type 1 diabetes). https://app.cochat.ai/papers/10.3390/medicina46080072
- The paper
- Skrodenienė, E., Marčiulionytė, D., Padaiga, Ž., Jašinskienė, E., Sadauskaitė-Kuehne, V., Sanjeevi, C., & Ludvigsson, J. (2010). HLA class II alleles and haplotypes in Lithuanian children with type 1 diabetes and healthy children (HLA and type 1 diabetes). Medicina. https://doi.org/10.3390/medicina46080072
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.